actg

(redirected from AIDS Clinical Trials Group)
Also found in: Medical, Wikipedia.

actg

abbreviation for
(Theatre) acting

actg.

acting.
References in periodicals archive ?
Investigators from the University of North Carolina, the University of Pittsburgh, and Yale University studied participants enrolled in the AIDS Clinical Trials Group (ACTG) HIV Reservoirs Cohort Study.
Schooley was chair of the National Institute of Allergy and Infectious Diseases' AIDS Clinical Trials Group. Before that, he served as associate professor of medicine at Harvard Medical School.
[8] The modified AIDS Clinical Trials Group (ACTG) staging system classifies AIDS-KS as either limited disease with a good prognosis or advanced disease with a poorer prognosis.
(5.) Villarino ME, Scott NA, Weis SE, et al.; International Maternal Pediatric and Adolescents AIDS Clinical Trials Group; Tuberculosis Trials Consortium.
We extracted the following data: demographic characteristics, baseline CD4+ count, HIV RNA viral load, haemoglobin concentration, other HIV-related comorbidities, date of KS diagnosis, KS site, AIDS Clinical Trials Group (ACTG) KS stage, [11, 12] HIV status, ART use, date of starting ART, chemotherapy and radiation therapy, date of last visit, and patient outcome.
AIDS Clinical Trials Group (ACTG) investigators explored the mortality impact of adherence to first-generation ART in ACTG protocol 362, a study of Mycobacterium avium prophylaxis in 643 people enrolled between October 1997 and April 1999.
The AIDS Clinical Trials Group [ACTG] Oncology Committee published criteria for the evaluation of epidemic Kaposi's sarcoma.
AIDS Clinical Trials Group (ACTG) researchers noted that blacks account for almost half of all new HIV infections in the United States and that HIV-positive blacks have a 9 times higher death rate than HIV-positive whites.' Numerous studies show that African Americans stop antiretroviral therapy sooner than others and that antiretroviral therapy fails more often in blacks.
According to the AIDS Clinical Trials Group (ACTG) staging system, the patient was classified as a poor-risk stage IV (T1,I1,S1) HIV/AIDS patient with a problem list of: (i) HIV-infected since 2009, receiving antiretroviral therapy (ART); (ii) CD4 count of 137 cells/[micro]l; (iii) 2 weeks of anti-TB treatment; (iv) KS since 2009 (for which she received multiple cycles of chemotherapy and palliative EBRT); (v) current presentation of bilateral, multi-lobular infiltrates on a CXR with a high index of suspicion of lung KS involvement; (vi) early signs of early diffuse intravascular coagulation (DIC); and (vii) pregnancy (28 weeks).
To explore this issue, the AIDS Clinical Trials Group (ACTG) OPTIONS (Optimized Treatment That Includes or Omits NRTIs) study enrolled 360 patients who had an HIV viral load of at least 1,000 copies/mL, were on a protease inhibitor--containing regimen, and had exposure or resistance to NRTIs and nonnucleoside reverse transcriptase inhibitors (NNRTIs).
and also received funding from the National Institute on Drug Abuse and the National Institute of Mental Health; the AIDS Clinical Trials Group, funded by NIAID also provided support for the study.
The findings were unveiled by the International Maternal Pediatric Adolescent AIDS Clinical Trials Group (IMPAACT) during the 2011 Conference on Retroviruses and Opportunistic Infections (CROI) in Boston.
Full browser ?